Frank Behrens

23PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersWomen's studies (incl. girls' studies)PharmacogenomicsArts therapyPhysiotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Feb 14, 2026
Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA).

Klaus Krueger, Frank Behrens, Jan Brandt-Juergens

|Oct 02, 2025
Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA register.

Lisa Lindner, Anja Weiß, Andreas Reich

|Aug 25, 2025
Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies.

Laura C Coates, Ricardo Blanco, Frank Behrens

|Sep 03, 2024
Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial.

Linda T Betz, Gitta A Jacob, Johannes Knitza

|Mar 18, 2024
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.

Lars Erik Kristensen, Mauro Keiserman, Kim Papp

|Feb 22, 2024
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL.

Laura C Coates, Robert Landewé, Iain B McInnes

Pageof 4

Frequent Collaborators

9 joint publications

Xenofon Baraliakos

5 joint publications

Michaela Koehm

5 joint publications

Anne Constanze Regierer

5 joint publications

Anja Weiß